Marion A.A. Libouban

Statistics

Publications

Citations

290

H-Index

Active since

2012

Affiliations

Center for Translational Molecular Medicine(Current)

Amsterdam UMC Location University of Amsterdam

University of Amsterdam

Marion A.A. Libouban is an author at Center for Translational Molecular Medicine specializing in dendritic cell regulation, life sciences, and oncology.

Publications per year

2012–2017

Publications

MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells

Julien J. Karrich, Loes C. M. Jachimowski, Marion A.A. Libouban et al. · Blood · 2013 · 89 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

TTK Inhibitors as a Targeted Therapy for <i>CTNNB1</i> ( <b>β</b> -catenin) Mutant Cancers

Guido J.R. Zaman, Jeroen A.D.M. de Roos, Marion A.A. Libouban et al. · Molecular Cancer Therapeutics · 2017 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity

Joost C.M. Uitdehaag, Jos de Man, Nicole Willemsen‐Seegers et al. · Journal of Molecular Biology · 2017 · 63 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1

Julien J. Karrich, Melania Balzarolo, Heike Schmidlin et al. · Blood · 2012 · 37 citations · Full text

Life Sciences, Cell Biology, Immunology +10

Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines

Marion A.A. Libouban, Jeroen A.D.M. de Roos, Joost C.M. Uitdehaag et al. · Oncotarget · 2017 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 5